Dyne Therapeutics (DYN)
(Delayed Data from NSDQ)
$24.73 USD
+1.04 (4.37%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $24.69 -0.04 (-0.16%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth F Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/09/2024
Time: -- |
3/2024 | $-0.80 | 0.18% |
Earnings Summary
For their last quarter, Dyne Therapeutics (DYN) reported earnings of -$1.09 per share, missing the Zacks Consensus Estimate of -$0.92 per share. This reflects a negative earnings surprise of 18.48%. Look out for DYN's next earnings release expected on May 09, 2024. For the next earning release, we expect the company to report earnings of -$0.80 per share, reflecting a year-over-year decrease of 2.56%.
Earnings History
Price & Consensus
Zacks News for DYN
5 Stocks to Buy as the Drug Industry Bets Big on Innovation
DYN: What are Zacks experts saying now?
Zacks Private Portfolio Services